Clinical efficacy of epinastine hydrochloride ophthalmic solution for allergic conjunctivitis

Clinical efficacy of epinastine hydrochloride ophthalmic solution for allergic conjunctivitis - Clinical efficacy of epinastine hydrochloride ophthalmic solution for allergic conjunctivitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016310

Enrollment

Registered

2015-02-01

Start date

2015-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic conjunctivitis

Interventions

Epinastine hydrochloride ophthalmic solution, apply 1 drop a time, 4 times daily, for 8 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients who has a positive result of type I allergy test by immuno-cap rapid 2)The planned patient who wears the contact lenses of the same product during a study

Exclusion criteria

Exclusion criteria: 1)The patient at the start of the test, it is determined that the continuously during the test period should not wear contact lenses 2)Females who are or may be pregnant, or lactating 3)Patients with a history of hypersensitivity to study drug or test material 4)Patient who the investigator considers ineligible for enrolment

Design outcomes

Primary

Measure	Time frame
Change in scores of subjective symptoms Change in scores of objective findings	—

Countries

Japan

Contacts

Public ContactHiroshi Kamezawa

Kamezawa EYE CLINIC Kamezawa EYE CLINIC

kamezawa-ganka@pearl.ocn.ne.jp045-731-1113

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026